Development and Evaluation of Chia Seed Mucilage-based Buccal Mucoadhesive, Sustained Release Tablet of Venlafaxine
DOI:
https://doi.org/10.37285/ijpsn.2016.9.6.4Abstract
In the present study we performed extraction of chia seed mucilage, formulation, and evaluation of buccal mucoadhesive tablet containing extracted mucialge and venlafaxine, an commonly used antidepressant. Tablets were prepared using a formulation mixture of calcium phosphate, talc and magnesium stearate. Tablets were prepared by experimental factorial design software, using central composite design; where the concentration of chia seeds mucilage and that of magnesium stearates were independent variables. Drug release, friability and mucoadhesive strength were studied as dependent variables. Tablets were characterized for post compression profile. The optimized formulation showed the maximum drug release as 99.4% in 6 h, friability of 0.53% and mucoadhesive strength of 20.3 g. These features appear to be adequate for developing a buccal mucoadhesive drug delivery system for venlafaxine.
Downloads
Metrics
Keywords:
Mucilage, venlafaxine, buccal tablets, sustained release, drug release, mucoadhesion, Chia seed mucilage
Downloads
Published
How to Cite
Issue
Section
References
Araujo J, Gonzalez-Mira E, Egea MA, Garcia ML and Souto EB (2010). Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Int J Pharm 393: 167-175.
Avachat A M, Dash R R and Shrotriya SN (2011). Recent investigations of plant based natural gums, mucilages and resins in novel drug delivery systems. Ind J Pharm Edu Res 45: 86-99.
Bangale GS, Shinde GV, Umalkar DG and Rajesh KS (2011). Natural mucoadhesive material based buccal tablets of nitrendipine-formulation and In-vitro evaluation. J Pharm Res 4(1): 33-38.
Desai KG and Kumar TMP (2004). Preparation and Evaluation of a novel buccal adhesive system. AAPS PharmSciTech 5: 1-9.
Edwin J, Edwin S, Dosi S, Raj A and Gupta S (2007). Application of hibiscus leaves mucilage as suspending agent. Ind J Pharm Edu Res 41: 373-375.
Eskandar M, Nasrin A andAkram A (2012). Formulation and Characterization of oral mucoadhesive chlorhexidine tablets using Cordia myxa mucilage. Jundishapur J Nat Pharm Prod 7(4): 129-133
Fan J, Wang K, Liu M and He Z (2008). In vitro evaluations of konjac glucomannon and xanthan gum mixture as the sustained release material of matrix tablet. Carbohydr Polyms 73(2): 241-247.
Gowthamrajan K, Jawahar N, Wake P, Jain K and Sood S (2012). Development of buccal tablets for curcumin using Anacardium occidentale gum. CarbohydrPolym 88: 1177-1183.
Hassan N, Khar NK, Mushir A and Javed A (2009). Development and evaluation of buccal bioadhesive tablet of an anti-emetic agent ondensetron. AAPS PharmSciTech 10(4): 1085-1092.
Hayashi T, Kanbe H, Okada M, Suzuki M, Ikeda Y, Onuki Y, Kaneko T and Sonobe T (2005). Formulation study and drug release mechanism of a new theophyline sustained- release preparation. Int J Pharm 304: 91-101.
Inampudi A, Adimoolam S, Bhosale R and Vantoor BNS (2012). Formulation and evaluation of venlafaxine hydrochloride mucoadhesive buccal tablets. Int J Pharm 3(1): 226 - 231.
Iqbal MS, Akbar J, Hussain MA, Saghir S and Sher M (2011). Evaluation of hot–water extracted arabinoxylans from isapghula seeds as drug carriers. Carbohydr Polym 83: 1218-1225.
Ishii K, Saiton Y, Yamada R, Itai S and Nemota M (1996). Novel approach for determination of correlation between in vivo and in vitro dissolution using the optimization technique.Chem Pharm Bull 44(8): 1550-1555.
Jian H, Zhu L, Zhang W, Sun D and Jiang J (2012). Galactomannan (from Gleditsia sinensis Lam.) and xanthan gum matrix tablets for controlled delivery of theophylline: In vitro drug release and swelling behavior. Carbohydr Polym 87(3): 2176-2182.
Kuei-Ying L, Daniel JR and Whistler RL (1994). Structure of chia seed polysaccharide exudate. Carbohydr Polym 23: 13-18.
Maiti S, Dey P, Banik A, Sa B, Ray S and Kaity S (2010). Tailoring of locust bean gum and development of hydrogel beads for controlled oral delivery of glipizide. Drug Deliv 17: 288-300.
Morales JO and McConville JT (2011). Manufacture and characterization of mucoadhesive buccal films. Eur J Pharm Biopharm 67(2): 187-199.
MunozLA, Cobos A, DiazO and Aguilera JM (2012). Chia seed: microstructure, mucilage extraction and hydration. J Food Eng 108: 216-224.
Nakhat PD, Kondawar A A, Rathi L G and Yeole PG (2008). Development and in vitro evaluation of buccoadhesive tablets of metoprolol tartrate. Ind J PharmSci 70(1): 121-124.
Nayak AK, Pal D and Das S (2013). Calcium pectinate-fenugreek seed mucilage mucoadhesive beads for controlled delivery of metformin HCl. Carbohydr Polym 96: 349-357.
Pani NR and Nath LK (2014). Development of controlled release tablet by optimizing HPMC: Consideration of theoretical release and RSM. Carbohydr Polym 104: 238-245.
Perioli I, Ambrogi V, Giovagnoli S, Ricci M, Blasi P and Rossi C (2007). Muoccoadhesive bilyaered tablets for buccal sustained release of flurbiprofen. AAPS PharmaSciTech 8(3): E1-E8.
Rana V, Rai P, Tiwary AK, Singh RS, Kennedy JF and Knill CJ (2011). Modified gums: Approaches, and applications in drug delivery, Carbohydr Polym 83: 1031-1047.
Satturwar MP, Fulzele VS and Dorle AK (2003). Biodegradation and in vivo biocompatibility of resin: A natural film- forming polymer. AAPS PharmSciTech 4: 434-439.
Savaser A, Ozkan Y and Isimer A (2005). Preparation and in vitro evaluation of sustained release tablet formulations of dichlofenac sodium. Il Farmaco 60: 171-177.
Shiledar RR, Tagalpallewar AA and Kokare CR (2014). Formulation and in vitro evaluation of xanthan gum based bilayered mucoadhesive buccal patches of zolmitriptan. Carbohydr Polym 101: 1234-1242.
Singh R, Maity S and Sa B (2014). Effect of ionic crosslink on the release of metronidazole from partially carboxymethylated guar gum tablet. Carbohydr Polym 106: 414-421.
Xiang- Gen W, Li G and Yong-Liang G (2006). Optimization of the preparation of nalmafene- loaded sustained release micropsheres using central composite design. Chem Pharm Bull 54(7): 977-981.
